3skin AS  
Oslo, Norway
|
3skin is an oncology biotech startup supported by the Oslo Cancer Cluster Incubator.
Member list of Oslo Cancer Cluster
Below you find a list of all members of Oslo Cancer Cluster in alphabetical order.
Results 1 - 20 out of 93 displayed.
|
AbbVie AS
Fornebu, Norway
|
AbbVie is a research-based biopharmaceutical company. The company's mission is to develop and market advanced therapies in the areas of hepatitis C (HCV), neuroscience, immunology, oncology, etc.
AbbVie AS is the sales and marketing arm of AbbVie Inc, USA.
|
Acapo AS
Bergen, Norway
|
Acapo AS is a full-serviced IPR-firm focused in the maintenance of patents, design and trademark registrations.
|
AdjuTec Pharma AS
Oslo, Norway
|
AdjuTec Pharma AS is a biotechnology company that developed low-toxic compounds adjuvants in combination with other antibiotics against multidrug-resistant gram-negative bacteria.
|
Advokatfirmaet Thommessen AS
Oslo, Norway
|
Advokatfirmaet Thommessen AS is an international law firm. The firm's areas of practice include banking, finance, intellectual property, capital markets, real estate, taxaton, mergers, and acquisitions.
|
AKERSHUS UNIVERSITETESSYKEHUS HF
Lørenskog, Norway
|
Akershus University Hospital (Ahus) provides treatments that safeguards and promotes patients health. The hospital delivers specialist in somatic health care, mental health and substance abuse.
|
Amgen Norge
Oslo, Norway
|
Amgen AB is active in clinical trials, medical information and scientific projects. The marketing department is responsible for disseminating information about marketed drugs for health professionals.
Amgen has a broad portfolio of biotechnological drugs in the fields of therapy oncology, hematology, nephrology, osteoporosis and cardiology.
|
APIM Therapeutics AS
Vanvikan, Norway
|
APIM Therapeutics AS renders biotechnology services. The company develops novel anti-cancer agents targeting deoxyribonucleic acid repair and cell cycle control through peptide compounds that penetrate cells, enter the nucleus, and target proliferating cell nuclear antigens.
|
Arctic Pharma AS
Oslo, Norway
|
Arctic Pharma AS is a privately held company, devoted to develop novel drugs and therapy in cancer and metabolic diseases.
|
Artemida Pharma
Hertfordshire, United Kingdom
|
Artemida Pharma is a specialist consultancy business established by a group of drug development experts, to provide strategic drug development consultancy and project management to start-up, biopharma and mid-sized pharma companies. The company is a provider of end-to-end services, encompassing strategic clinical, regulatory and commercial expertise, along with a focus on technical pharmaceutical development of small molecules and biological agents.
|
Astellas Pharma
Asker, Norway
|
Astellas Pharma is a research-oriented global pharmaceutical company operating in about 50 countries with a focus on ethical pharmaceuticals. The company focuses on the areas like urology, immunology, infectious diseases, oncology, neuroscience, etc.
|
AstraZeneca AS
Oslo, Norway
|
AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for cardiovascular, gastrointestinal, neuroscience, infection, oncology, and respiratory and inflammation diseases worldwide. The company's principal products include Atacand for hypertension and heart failure; Crestor for managing cholesterol levels; Seloken/Toprol-XL for hypertension, heart failure, and angina; Nexium for acid reflux; Synagis for RSV, a respiratory infection in infants; Seroquel...
|
Balter Medical AS
Bergen, Norway
|
Balter Medical aims to develop and commercialize medical applications of the Optical Transfer Theory, which is a mathematical modeling technique using digital photographic images (pictures) to understand the properties of the subject in the picture. The company has successfully developed a medical imaging device (BM-Dermatoscope) and a diagnostic algorithm [Optical Transfer Diagnosis (OTD)] for detecting anomalies in human tissue. The first BM-OTD application is a device and an algorithm to...
|
Bayer AS
Oslo, Norway
|
Bayer AS's main activities consist of sale, service and marketing of the Bayer Group and Lanxess products. The activities are divided into six operating units: pharmaceuticals, consumer health, crop science, animal health, Bayer Garden, Bayer Agency Business.
|
BerGenBio ASA
Bergen, Norway
|
BerGenBio is a clinical-stage oncology company advancing first-in-class, selective AXL kinase inhibitors as a potential cornerstone of combination therapy for multiple cancers. The company's lead product, Bemcentinib (BGB324) is a potent, selective and orally bioavailable AXL inhibitor and the most-advanced selective AXL inhibitor in clinical trials.
|
Birk Venture
Oslo, Norway
|
Birk Venture is a venture capital firm specializing in early stage. The firm invests in small size and start-up companies with a unique technology. The company exclusively invests in the life science industry with a special focus on pharmaceuticals, biotechnology, diagnostics, medical devices and instruments, and consumer health.
|
Bristol-Myers Squibb Norway
Lysaker, Norway
|
Bristol-Myers Squibb operates as a biopharmaceutical company, which engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of biopharmaceutical products. The company in Norway focuses on sales and services and also supports hospital clown.
|
Bryn Aarflot AS
Oslo, Norway
|
Bryn Aarflot AS is a consulting firm, providing assistance to inventors, start-ups, companies and others within all areas of intellectual property law. The company's teams of lawyers and patent attorneys provide the service level in IP advising through the process from innovation to commercialisation.
|
Catapult Life Science AS
Fornebu, Norway
|
The Catapult Life Science provides facilities and services for pilot scale development of products and process technology for the life science industry, including biotechnology, chemistry, and medicine. The services comprise upscaling of chemistry, preparation of powders, fermentation, production, and quality control.
|
Celgene AS
Oslo, Norway
|
Celgene is an international biopharmaceutical company focused on discovering, bringing the development and marketing of innovative medicines which are particularly aimed at treatment of cancer, immune and inflammatory diseases.